News & Press Releases

NEWS

Presentation of Saturn at PCR London Valve – November 2023

Presentation of Saturn at PCR London Valve – November 2023

Our technology and transapical clinical results have been presented at 2023 PCR London Valve held on November 24-26 in Excel Center, London, UK. Specifically, Dr. Paolo Denti, MD held a presentation named "the Saturn TMVR Trans-apical FHU study: Two-year Trans-apical...

InnovHeart Featured in MedTech Strategist

InnovHeart Featured in MedTech Strategist

We are pleased to announce that InnovHeart is featured in the MedTech Strategist October 2023 edition. The article "The Tantalizing Mitral Valve Device Market” by author Mary Stuart captures well InnovHeart’s commitment to enhancing the quality of life for millions of...

Presentation of Saturn at TVT – June 2023

Presentation of Saturn at TVT – June 2023

View presentations on the novel SATURN TMVR technology with transseptal delivery, developed by Dr. Lauren S. Ranard in collaboration with Dr. Torsten Vahl, Dr. Paolo Denti, the staff from Skirball Center for Innovation, and InnovHeart R&D team, and presented at...

Presentation of Saturn at TCT – September 2022

Presentation of Saturn at TCT – September 2022

Our technology has been presented at 2022 TCT held on September 16-19 in Boston, MA. Specifically, Dr. Paolo Denti, MD held a presentation about our Trans-apical FHU Study: 2-Years follow up, showing solid and effective data. Dr. Lauren S. Ranard, MD illustrated a...

Presentation of Saturn at TVT 2022 – June 2022

Presentation of Saturn at TVT 2022 – June 2022

Our technology has been presented at 2022 TVT held on June 8-10 in Chicago, IL. Specifically, Dr. Paolo Denti, MD, spoke about "Trans-apical FHU Study: 1-Year follow up". Full video available here.

PRESS RELEASES

InnovHeart appoints David Wilson as Chief Executive Officer

InnovHeart appoints David Wilson as Chief Executive Officer

Industry Leader to Guide Company and the Saturn TMVR Programin its Next Phase of Growth  InnovHeart s.r.l. announced today the appointment of David James Wilson, an experienced healthcare and medical device executive as Chief Executive Officer of the company and...